Table Of Contents
Ex-AstraZeneca Senior Director Sues Over Unpaid Bonuses and Stock Options
AstraZeneca Pharmaceuticals LP, the pharmaceutical giant, gained major prominence during the COVID-19 pandemic. It was a leading manufacturer of the COVID-19 vaccine that millions around the world took as a precautionary measure.
However, the company is facing a lawsuit in the United States. A former senior director is suing on grounds that the drugmaker is not paying her properly.
The Drug Giant was supposed to pay her around $130,000 in the form of bonuses and stock options. This benefit is available to full-time employees. However, according to the lawsuit, the company refuses to pay her.
Elmarie Bodes, the plaintiff of the lawsuit, was AstraZeneca’s senior director of business transformation. She left the job in January.
She filed the lawsuit in South Carolina state court. This lawsuit from Tuesday states that she is yet to receive a $124,000 performance bonus and $65,000 in the form of stock options.
However, AstraZeneca decided to illegally cut down her payment into half. They also refused to give her any stock options. They are showing the reason for her not coming into the office at least three days per week. These accusations come despite her being a full-time work-from-home employee, according to the lawsuit.
AstraZeneca, the pharmaceutical giant, is based in London. It has U.S. headquarters in Delaware. The company chose not to respond immediately.
Read Also:
